A Transgenic Alzheimer Rat with Plaques, Tau Pathology, Behavioral Impairment, Oligomeric Aβ, and Frank Neuronal Loss
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is hallmarked by amyloid plaques, neurofibrillary tangles, and widespread cortical neuronal loss (Selkoe, 2001). The “amyloid cascade hypothesis” posits that cerebral amyloid sets neurotoxic events into motion that precipitate Alzheimer dementia (Hardy and Allsop, 1991). Yet, faithful recapitulation of all AD features in widely used transgenic (Tg) mice engineered to overproduce Aβ peptides has been elusive. We have developed a Tg rat model (line TgF344-AD) expressing mutant human amyloid precursor protein ( APP sw ) and presenilin 1 ( PS1 Δ E9 ) genes, each independent causes of early-onset familial AD. TgF344-AD rats manifest age-dependent cerebral amyloidosis that precedes tauopathy, gliosis, apoptotic loss of neurons in the cerebral cortex and hippocampus, and cognitive disturbance. These results demonstrate progressive neurodegeneration of the Alzheimer type in these animals. The TgF344-AD rat fills a critical need for a next-generation animal model to enable basic and translational AD research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · cited 7×
“…and 14Medicine, David Geffen School of Medicine, and 15Brain Research Institute, University of California, Los Angeles, Los Angeles, California 90048 Alzheimer’s disease (AD) is hallmarked by amyloid plaques, neurofibrillary tangles, and widespread cortical neuronal loss (Selkoe, 2001).”
InfluentialAChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., Watson, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,497
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“To further examine this possibility, we performed immunohistochemical analysis using OC, a conformational antibody that recognizes soluble oligomeric fibrillar A (Kayed et al., 2003; Kayed and Glabe, 2006).”
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 3×
“While A -driven rodent models of AD also exhibit brain amyloidosis (Games et al., 1995; Hsiao et al., 1996; Holcomb et al., 1998; Oddo et al., 2003; Oakley et al., 2006; Lawlor et al., 2007; Liu et al., 2008; Leon et al., 2010), cerebral A abundance in TgF344-AD rats ( 60 g/wet g of brain in aged animals) is high enou…”
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 5×
“The “amyloid cascade hypothesis” posits that cerebral amyloid sets neurotoxic events into motion that precipitate Alzheimer dementia (Hardy and Allsop, 1991).”
InfluentialAlzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 2×
“Yet, one of the key critiques of the hypothesis is that the “gold standard” animal models of the disease, A -overproducing Tg AD mice (Games et al., 1995; Hsiao et al., 1996; Sturchler-Pierrat et al., 1997; Holcomb et al., 1998; Mucke et al., 2000; Jankowsky et al., 2001), do not demonstrate robust…”
BackgroundMemory deficits associated with senescence: A neurophysiological and behavioral study in the rat.
Barnes, C. A. (1979) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0077579 · Cited by 2,088
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“…models of the disease, A -overproducing Tg AD mice (Games et al., 1995; Hsiao et al., 1996; Sturchler-Pierrat et al., 1997; Holcomb et al., 1998; Mucke et al., 2000; Jankowsky et al., 2001), do not demonstrate robust tauopathy and neuronal loss unless additional human transgenes are included…”
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 1×
“These observations fall in line with recent data suggesting a link among caspase-3 activation, tauopathy, and neuronal apoptosis (Ittner et al., 2010; de Calignon et al., 2010).”
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530 · cited 1×
“…et al., 2010), cerebral A abundance in TgF344-AD rats ( 60 g/wet g of brain in aged animals) is high enough to be within the clinicopathological range of the human syndrome [ 50 –1000 g/wet g of brain (Lue et al., 1999; Delacourte et al., 2002; Ingelsson et al., 2004; Steinerman et al., 2008)].”
BackgroundTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · cited 4×
“Tauopathy in TgF344-AD rats APP and PS1 mutations increase brain A abundance but do not precipitate frank neurofibrillary tangles (NFTs) in Tg mouse models of cerebral amyloidosis (Games et al., 1995; Duff et al., 1996; Hsiao et al., 1996; Sturchler-Pierrat et al., 1997; Holcomb et al., 1998; Mucke et al., 2000; Janko…”
InfluentialIncreased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,465
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
Jankowsky, J. L., Slunt, H. H., Ratovitski, T., Jenkins, N. A., Copeland, N. G., & Borchelt, D. R. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00067-3 · Cited by 746
PET of Brain Amyloid and Tau in Mild Cognitive Impairment
Small, G. W., Kepe, V., Ercoli, L. M., Siddarth, P., Bookheimer, S. Y., Miller, K. J., Lavretsky, H., Burggren, A. C., Cole, G. M., Vinters, H. V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054625 · Cited by 738
Self-citationGreenberg, S. G., & Davies, P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5827 · Cited by 730
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
Ingelsson, M., Fukumoto, H., Newell, K. L., Growdon, J. H., Hedley–Whyte, E. T., Frosch, M. P., Albert, M. S., Hyman, B. T., & Irizarry, M. C. (2004) · Neurology · doi:10.1212/01.wnl.0000115115.98960.37 · Cited by 666 · cited 1×
“…et al., 2010), cerebral A abundance in TgF344-AD rats ( 60 g/wet g of brain in aged animals) is high enough to be within the clinicopathological range of the human syndrome [ 50 –1000 g/wet g of brain (Lue et al., 1999; Delacourte et al., 2002; Ingelsson et al., 2004; Steinerman et al., 2008)].”
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
Wyss-Coray, T., Lin, C., Yan, F., Yu, G.-Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) · Nature Medicine · doi:10.1038/87945 · Cited by 587
Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996) · Neurology · doi:10.1212/wnl.46.6.1592 · Cited by 561
(1997) · doi:10.1073/pnas.94.4.1550 · Cited by 535
Caspase activation precedes and leads to tangles
de Calignon, A., Fox, L. M., Pitstick, R., Carlson, G. A., Bacskai, B. J., Spires-Jones, T. L., & Hyman, B. T. (2010) · Nature · doi:10.1038/nature08890 · Cited by 517
Amyloid-β oligomers: their production, toxicity and therapeutic inhibition
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Rowan, M. J., & Selkoe, D. J. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300552 · Cited by 507
Neuron loss in APP transgenic mice
Calhoun, M. E., Wiederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., & Jucker, M. (1998) · Nature · doi:10.1038/27351 · Cited by 502 · cited 1×
“Finally, neuronal loss in other rodent models of AD is either absent entirely or quantitatively minor, or only present in a limited subset of brain areas classically affected in human AD (Calhoun et al., 1998; Oddo et al., 2003; Oakley et al., 2006; Rebeck et al., 2010).”
Different Contributions of the Hippocampus and Perirhinal Cortex to Recognition Memory
Wan, H., Aggleton, J. P., & Brown, M. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-03-01142.1999 · Cited by 447
Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology
Town, T., Laouar, Y., Pittenger, C., Mori, T., Szekely, C. A., Tan, J., Duman, R. S., & Flavell, R. A. (2008) · Nature Medicine · doi:10.1038/nm1781 · Cited by 422 · cited 1×
“Separate sandwich ELISAs for A 1– 40 and A 1– 42 in both detergent-insoluble and -soluble brain extracts (Johnson-Wood et al., 1997; Tan et al., 2002; Town et al., 2008) revealed significant (p 0.001) progressive increases for both fractions of A 1– 40 and A 1– 42 in Tg rats (Fig.”
InfluentialSelf-citationAgdeppa, E. D., Kepe, V., Liu, J., Flores-Torres, S., Satyamurthy, N., Petric, A., Cole, G. M., Small, G. W., Huang, S.-C., & Barrio, J. R. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-j0004.2001 · Cited by 419
Self-citationAmyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease
Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., & Mucke, L. (1997) · Nature · doi:10.1038/39321 · Cited by 417 · cited 1×
“CAA analyses were conducted as previously described (Wyss-Coray et al., 1997; Wyss-Coray et al., 2001), and revealed copious (Fig.”
The Oligomerization of Amyloid β-Protein Begins Intracellularly in Cells Derived from Human Brain
Walsh, D. M., Tseng, B. P., Rydel, R. E., Podlisny, M. B., & Selkoe, D. J. (2000) · Biochemistry · doi:10.1021/bi001048s · Cited by 401
Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.
Joachim, C. L., Morris, J. H., & Selkoe, D. J. (1989) · PubMed Central · Cited by 385
A potential role for apoptosis in neurodegeneration and Alzheimer's disease
Cotman, C. W., & Anderson, A. J. (1995) · Molecular Neurobiology · doi:10.1007/bf02740836 · Cited by 378
Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling
Gorman, A. M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00402.x · Cited by 362 · cited 1×
“That TgF344-AD rats show clear evidence of age-dependent neuronal loss is interesting given the ongoing debate surrounding mechanisms of neuronal loss in AD (Cotman and Anderson, 1995; Behl, 2000; Zhu et al., 2006; Gorman, 2008).”
Microglial Activation Resulting from CD40-CD40L Interaction After β-Amyloid Stimulation
Tan, J., Town, T., Paris, D., Mori, T., Suo, Z., Crawford, F., Mattson, M. P., Flavell, R. A., & Mullan, M. (1999) · Science · doi:10.1126/science.286.5448.2352 · Cited by 352
Self-citationSu, J. H., Zhao, M., Anderson, A. J., Srinivasan, A., & Cotman, C. W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02018-2 · Cited by 260
Rozemuller, J. M., Eikelenboom, P., Stam, F. C., Beyreuther, K., & Masters, C. L. (1989) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198911000-00009 · Cited by 243
LTP saturation and spatial learning disruption: effects of task variables and saturation levels
Barnes, C., Jung, M., McNaughton, B., Korol, D., Andreasson, K., & Worley, P. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-10-05793.1994 · Cited by 221
Leon, W. C., Canneva, F., Partridge, V., Allard, S., Ferretti, M. T., DeWilde, A., Vercauteren, F., Atifeh, R., Ducatenzeiler, A., Klein, W., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1349 · Cited by 221
Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice
Tan, J., Town, T., Crawford, F., Mori, T., DelleDonne, A., Crescentini, R., Obregon, D., Flavell, R. A., & Mullan, M. J. (2002) · Nature Neuroscience · doi:10.1038/nn968 · Cited by 217 · cited 3×
“Separate sandwich ELISAs for A 1– 40 and A 1– 42 in both detergent-insoluble and -soluble brain extracts (Johnson-Wood et al., 1997; Tan et al., 2002; Town et al., 2008) revealed significant (p 0.001) progressive increases for both fractions of A 1– 40 and A 1– 42 in Tg rats (Fig.”
InfluentialSelf-citationMethylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization
Necula, M., Breydo, L., Milton, S., Kayed, R., van der Veer, W. E., Tone, P., & Glabe, C. G. (2007) · Biochemistry · doi:10.1021/bi700411k · Cited by 213
Self-citationAlzheimer Disease: DMA Fragmentation Indicates Increased Neuronal Vulnerability, but not Apoptosis
Stadelmann, C., Brück, W., Bancher, C., Jellinger, K., & Lassmann, H. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199805000-00009 · Cited by 208
Apoptosis and Alzheimer's disease
Behl, C. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070021 · Cited by 193
Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes.
Braak, H., & Braak, E. (1990) · PubMed · Cited by 189
Tau isoform regulation is region‐ and cell‐specific in mouse brain
McMillan, P., Korvatska, E., Poorkaj, P., Evstafjeva, Z., Robinson, L., Greenup, L., Leverenz, J., Schellenberg, G. D., & D'Souza, I. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21867 · Cited by 179 · cited 1×
“Furthermore, rats have the full complement of six tau isoforms present in humans, whereas mice only harbor three of the human tau isoforms (McMillan et al., 2008; Hanes et al., 2009).”
Alzheimerʼs Disease: Striatal Amyloid Deposits and Neurofibrillary Changes
BRAAK, H., & BRAAK, E. (1990) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199005000-00003 · Cited by 173
Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer’s disease
Delacourte, A., Sergeant, N., Champain, D., Wattez, A., Maurage, C.-A., Lebert, F., Pasquier, F., & David, J.-P. (2002) · Neurology · doi:10.1212/wnl.59.3.398 · Cited by 168
Conformation‐Dependent Anti‐Amyloid Oligomer Antibodies
Kayed, R., & Glabe, C. G. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)13017-7 · Cited by 166
Self-citationWilcock, D. M., Lewis, M. R., Van Nostrand, W. E., Davis, J., Previti, M. L., Gharkholonarehe, N., Vitek, M. P., & Colton, C. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5066-07.2008 · Cited by 162
Alzheimer's disease: amyloid plaques in the cerebellum
Braak, H., Braak, E., Böhl, J., & Lang, W. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90197-4 · Cited by 157
Padmanabhan, J., Levy, M., Dickson, D. W., & Potter, H. (2006) · Brain · doi:10.1093/brain/awl255 · Cited by 120
Liu, L., Orozco, I. J., Planel, E., Wen, Y., Bretteville, A., Krishnamurthy, P., Wang, L., Herman, M., Figueroa, H. Y., Yu, W. H., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.03.005 · Cited by 120
Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies
Hanes, J., Zilka, N., Bartkova, M., Caletkova, M., Dobrota, D., & Novak, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05869.x · Cited by 109 · cited 3×
“…using Tau-PADRE antibody revealed six bands 48 – 62 kDa in size (data not shown), which likely contain six isoforms of rat tau that are similar to those present in the human (Hanes et al., 2009), and pTau-PADRE WB revealed increased immunoreactivity in aged TgF344-AD versus WT rats (Fig.”
Dickson, D. W., Wertkin, A. M., Mattiace, L. A., Fier, E., Kress, Y., Davies, P., & Yen, S. H. (1990) · Acta Neuropathologica · doi:10.1007/bf00296107 · Cited by 106
Distinct Pools of β-Amyloid in Alzheimer Disease–Affected Brain: A Clinicopathologic Study
Steinerman, J. R., Irizarry, M., Scarmeas, N., Raju, S., Brandt, J., Albert, M., Blacker, D., Hyman, B., & Stern, Y. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.906 · Cited by 104 · cited 1×
“…et al., 2010), cerebral A abundance in TgF344-AD rats ( 60 g/wet g of brain in aged animals) is high enough to be within the clinicopathological range of the human syndrome [ 50 –1000 g/wet g of brain (Lue et al., 1999; Delacourte et al., 2002; Ingelsson et al., 2004; Steinerman et al., 2008)].”
The Effects of NOS2 Gene Deletion on Mice Expressing Mutated Human AβPP
Colton, C. A., Wilcock, D. M., Wink, D. A., Davis, J., Van Nostrand, W. E., & Vitek, M. P. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15405 · Cited by 95
First transgenic rat model developing progressive cortical neurofibrillary tangles
Filipčík, P., Žilka, N., Bugos, O., Kučerák, J., Koson, P., Novák, P., & Novák, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.015 · Cited by 94
Apoptosis in Alzheimer Disease: A Mathematical Improbability
Zhu, X., Raina, A., Perry, G., & Smith, M. (2006) · Current Alzheimer Research · doi:10.2174/156720506778249470 · Cited by 85
Patterns of Insertions and Their Covariation With Substitutions in the Rat, Mouse, and Human Genomes
Yang, S., Smit, A. F., Schwartz, S., Chiaromonte, F., Roskin, K. M., Haussler, D., Miller, W., & Hardison, R. C. (2004) · Genome Research · doi:10.1101/gr.1984404 · Cited by 84
LAMY, C., DUYCKAERTS, C., DELAERE, P., PAYAN, C., FERMANIAN, J., POULAIN, V., & HAUW, J. J. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01255.x · Cited by 81
Amyloid Oligomer Conformation in a Group of Natively Folded Proteins
Yoshiike, Y., Minai, R., Matsuo, Y., Chen, Y., Kimura, T., & Takashima, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003235 · Cited by 76
Lawlor, P. A., Bland, R. J., Das, P., Price, R. W., Holloway, V., Smithson, L., Dicker, B. L., During, M. J., Young, D., & Golde, T. E. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-11 · Cited by 67 · cited 1×
“…models of AD also exhibit brain amyloidosis (Games et al., 1995; Hsiao et al., 1996; Holcomb et al., 1998; Oddo et al., 2003; Oakley et al., 2006; Lawlor et al., 2007; Liu et al., 2008; Leon et al., 2010), cerebral A abundance in TgF344-AD rats ( 60 g/wet g of brain in aged animals) is high…”
Rebeck, G. W., Hoe, H.-S., & Moussa, C. E.-H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083915 · Cited by 54
Rosenwld, A., Reusche, E., Ogomori, K., & Teichert, H.-M. (1993) · Acta Neuropathologica · doi:10.1007/bf00334887 · Cited by 29
Cited by
A three-dimensional human neural cell culture model of Alzheimer’s disease
Choi, S. H., Kim, Y. H., Hebisch, M., Sliwinski, C., Lee, S., D’Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., et al. (2014) · Nature · doi:10.1038/nature13800 · Cited by 1,195
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
“Increased levels of p-tau and conformationally altered tau were observed in transgenic rat brain overexpressing AD-associated APP/PS1 mutations in a wild-type tau background [292, 293].”
BackgroundThe Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
Cline, E. N., Bicca, M. A., Viola, K. L., & Klein, W. L. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179941 · Cited by 870
Alzheimer's disease: experimental models and reality
Drummond, E., & Wisniewski, T. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1662-x · Cited by 810
“These mice develop NFTs, neurodegeneration, atrophy and motor deficits.”
BackgroundInfluentialBiology and Genetics of Prions Causing Neurodegeneration
Prusiner, S. B. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155524 · Cited by 455
“Although no authentic animal models of AD exist, much has been learned from mice, and more recently Tg rats (22), that express mutant human APP transgenes.”
Metadata
- Authors
- Cohen, R. M., Rezai-Zadeh, K., Weitz, T. M., Rentsendorj, A., Gate, D., Spivak, I., Bholat, Y., Vasilevko, V., Glabe, C. G., Breunig, J. J., Rakic, P., Davtyan, H., Agadjanyan, M. G., Kepe, V., Barrio, J. R., Bannykh, S., Szekely, C. A., Pechnick, R. N., & Town, T.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2013-04-10
- Volume
- 33
- Issue
- 15
- Pages
- 6245-6256
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2166578434
- Cited by
- 531
- References
- 66
- FWCI
- 17.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.